Provided by Tiger Trade Technology Pte. Ltd.

Park Hotels & Resorts Inc.

15.53
+0.11000.71%
Post-market: 15.530.00000.00%19:30 EDT
Volume:3.29M
Turnover:51.08M
Market Cap:3.13B
PE:-18.79
High:15.62
Open:15.62
Low:15.39
Close:15.42
52wk High:16.20
52wk Low:9.84
Shares:201.40M
Float Shares:195.63M
Volume Ratio:0.94
T/O Rate:1.68%
Dividend:1
Dividend Rate:6.44%
EPS(TTM):-0.8265
EPS(LYR):-1.4300
ROE:-4.86%
ROA:2.75%
PB:1.01
PE(LYR):-10.86

Loading ...

Arcutis Submits Supplemental New Drug Application to the FDA for ZORYVE® (roflumilast) Cream 0.05% to Expand Indication for Treatment of Atopic Dermatitis to Infants Down to 3 Months

GlobeNewswire
·
Apr 27

Hilton plans 15 new hotels in Morocco to double portfolio to 25 properties

Reuters
·
Apr 24

Earning Preview: Park Hotels & Resorts Inc. this quarter’s revenue is expected to decrease by 0.21%, and institutional views are bearish

Earnings Agent
·
Apr 24

RenovoRx Announces Pharmacokinetic and Pharmacodynamic Data Abstract Supporting the TAMP™ Therapy Platform Accepted for Presentation at the 2026 ASCO Annual Meeting

GlobeNewswire
·
Apr 23

Press Release: Addex Spin-Out Company Neurosterix on Track to Complete Phase 1 Clinical Study of NTX-253 for Schizophrenia in Q2 2026

Dow Jones
·
Apr 23

Avacta data at AACR 2026 underline favorable profile of AVA6103 and advantages of pre|CISION® delivery platform

GlobeNewswire
·
Apr 22

LUYE PHARMA's Innovative Drug LY03015 Enrolls First Patient in US Pharmacokinetic Bridging Study

Stock News
·
Apr 20

Luye Pharma Starts U.S. PK Bridging Trial for Novel CNS Drug LY03015

TIPRANKS
·
Apr 20

Comparison of Major Brokerages' Overseas Expansion: Who Leads the Pack?

Deep News
·
Apr 13

ArkBio Completed Dosing of First Cohort in Australian Phase I Trial of Antiviral Drug-Fc Conjugate Drug AK0406

prnewswire
·
Apr 10

Nurix Therapeutics Reports First Quarter 2026 Financial Results and Provides a Corporate Update

GlobeNewswire
·
Apr 08

Comparison of Trading Platforms for Novice Fund Investors: Three Leading Apps Recommended

Deep News
·
Apr 08

Park Hotels & Resorts Cut to Equal-Weight From Overweight by Barclays

Dow Jones
·
Apr 07

Barclays Downgrades Park Hotels & Resorts to Equalweight From Overweight, Adjusts Price Target to $9 From $13

MT Newswires Live
·
Apr 07

Park Hotels & Resorts (PK) was downgraded to a Hold Rating at Barclays

TIPRANKS
·
Apr 07